Tranilast
- Generic Name
- Tranilast
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C18H17NO5
- CAS Number
- 53902-12-8
- Unique Ingredient Identifier
- HVF50SMY6E
- Background
Tranilast is an antiallergic drug developed by Kissei Pharmaceuticals. In 1982, it was approved in Japan and South Korea for the management of bronchial asthma. Indications for keloid and hypertrophic scar were added in 1993. It has been used for the treatment of allergic disorders such as asthma, allergic rhinitis and atopic dermatitis.
- Indication
For the treatment of bronchial asthma, keloid and hypertrophic scar, and allergic disorders such as asthma, allergic rhinitis and atopic dermatitis.
- Associated Conditions
- -
- Associated Therapies
- -
Safety and Efficacy Study of Tranilast in Patients With Active Rheumatoid Arthritis (RA)
- First Posted Date
- 2009-04-16
- Last Posted Date
- 2011-01-06
- Lead Sponsor
- Nuon Therapeutics, Inc.
- Target Recruit Count
- 250
- Registration Number
- NCT00882024
Effects of Tranilast on Pharmacokinetics of Methotrexate (MTX) in Patients With Rheumatoid Arthritis (RA)
- First Posted Date
- 2008-07-18
- Last Posted Date
- 2015-05-28
- Lead Sponsor
- Imperial College London
- Registration Number
- NCT00717808
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath